This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Delcor Asset Corporation, Delcor Assett Corporation. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: Kuljit Bhatia: Innovator in Pharmaceutical Composition
Introduction
Kuljit Bhatia is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of innovative corticosteroid products. With a total of 3 patents to his name, Bhatia's work has the potential to impact the treatment of various skin conditions.
Latest Patents
Bhatia's latest patents include a groundbreaking spray foam corticosteroid product. This invention discloses a foamable pharmaceutical composition designed to treat corticosteroid-responsive dermatoses of the skin. The composition features a corticosteroid compound as the active ingredient, combined with a quick-break foaming agent that includes an aliphatic alcohol, water, a fatty alcohol, and a surface-active agent. Additionally, it contains a buffering agent and a propellant. The foamable composition is stored in a pressurizable container equipped with an aerosol valve assembly. This assembly includes a dip tube that communicates with a valve orifice, allowing for the controlled dispensation of the foamable composition. The valve assembly is designed to dispense a conically-shaped spray at a rate of about 2 to 0.3 g/sec, producing a foam with a density ranging from about 0.12 to 0.25 when sprayed from a distance of 5 to 10 cm onto a glass surface at ambient room temperature.
Career Highlights
Throughout his career, Kuljit Bhatia has worked with various companies, including Delcor Asset Corporation. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of corticosteroid treatments.
Collaborations
Bhatia has collaborated with professionals such as Michael V Lowenborg, contributing to the advancement of his inventions and enhancing their practical applications.
Conclusion
Kuljit Bhatia's contributions to the field of pharmaceutical compositions, particularly through his innovative corticosteroid products, demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of skin conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile